Kevin Bourinot

Kevin Bourinot has an extensive background in quality control and analytical development within the pharmaceutical and biotechnology industries. Currently serving as Associate Director of Quality Control and Analytical Development at Apogee Therapeutics since April 2024, Kevin previously held the position of Associate Director of Analytical Sciences and Quality Testing at Kiniksa Pharmaceuticals from October 2022 to March 2024. Prior to that, Kevin spent over 14 years at Bristol Myers Squibb in various roles including Senior Manager of Quality Control Operations and Technical Support. Earlier experience includes positions at Lonza, Microtest Laboratories, and Westfield State University, focusing on quality control microbiology and analytical chemistry. Kevin holds a Master of Science in Bioscience Administration from Worcester Polytechnic Institute and a Bachelor of Science in Cellular and Molecular Biology and Chemistry from Westfield State University.